ARTICLE | Company News
Boehringer Ingelheim, Eli Lilly deal
February 20, 2006 8:00 AM UTC
LLY will repurchase from Boehringer worldwide rights to Yentreve/ AriClaim duloxetine for stress urinary incontinence (SUI) and related indications. The companies had been co-marketing the drug for S...